tetano
Editor, Senior Moderator
PLoS One. 2018 Nov 15;13(11):e0207431. doi: 10.1371/journal.pone.0207431. eCollection 2018.
[h=1]A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.[/h] Zhao H[SUP]1[/SUP], Xu K[SUP]1[/SUP], Jiang Z[SUP]1[/SUP], Shao M[SUP]1[/SUP], Liu S[SUP]1[/SUP], Li X[SUP]2,[/SUP][SUP]3[/SUP], Wang J[SUP]1[/SUP], Li C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Outbreaks of the highly pathogenic avian influenza H5N1 and H7N9 viruses have spurred an unprecedented research effort to develop antivirals and vaccines against influenza. Standardized methods for vaccine evaluation are critical for facilitating vaccine development. Compared with hemagglutination inhibition assays, mounting evidence suggest that microneutralization tests (MNTs) is a better choice for the evaluation of candidate pandemic influenza vaccines because they measure neutralizing antibody activity in cell cultures and are more sensitive in detecting H5 and H7. Here, we report a MNT measuring neuraminidase activity as the read-out (NA-MNT) for quantitative analysis of neutralizing antibodies against avian influenza viruses. Compared to the conventional microneutralization assay (ELISA-MNT), the NA-MNT is faster with lower intra- and inter-assay variations, while no difference in geometric mean titers was found between these two assays for the evaluation of H5N1 and H7N9 vaccines. These results suggest that NA-MNT is a reliable and high throughput method which could facilitate the development of candidate pandemic influenza vaccine.
PMID: 30440054 DOI: 10.1371/journal.pone.0207431
[h=1]A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.[/h] Zhao H[SUP]1[/SUP], Xu K[SUP]1[/SUP], Jiang Z[SUP]1[/SUP], Shao M[SUP]1[/SUP], Liu S[SUP]1[/SUP], Li X[SUP]2,[/SUP][SUP]3[/SUP], Wang J[SUP]1[/SUP], Li C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Outbreaks of the highly pathogenic avian influenza H5N1 and H7N9 viruses have spurred an unprecedented research effort to develop antivirals and vaccines against influenza. Standardized methods for vaccine evaluation are critical for facilitating vaccine development. Compared with hemagglutination inhibition assays, mounting evidence suggest that microneutralization tests (MNTs) is a better choice for the evaluation of candidate pandemic influenza vaccines because they measure neutralizing antibody activity in cell cultures and are more sensitive in detecting H5 and H7. Here, we report a MNT measuring neuraminidase activity as the read-out (NA-MNT) for quantitative analysis of neutralizing antibodies against avian influenza viruses. Compared to the conventional microneutralization assay (ELISA-MNT), the NA-MNT is faster with lower intra- and inter-assay variations, while no difference in geometric mean titers was found between these two assays for the evaluation of H5N1 and H7N9 vaccines. These results suggest that NA-MNT is a reliable and high throughput method which could facilitate the development of candidate pandemic influenza vaccine.
PMID: 30440054 DOI: 10.1371/journal.pone.0207431